UB Paderborn / Katalog / Suche / in CDI

The Plasminogen Activator Inhibitor PAI-1 Controls in Vivo Tumor Vascularization by Interaction with Proteases, Not Vitronectin: Implications for Antiangiogenic Strategies

The Journal of cell biology, 2001-02, Vol.152 (4), p.777-784

2001

Volltextzugriff (PDF)

Integrated Database of Eight Prospective IgG Studies in Primary Immunodeficiency: New Tool for Pooled Analysis

Journal of allergy and clinical immunology, 2012-02, Vol.129 (2), p.AB193-AB193

2012

Volltextzugriff (PDF)

Ksp-cadherin is a functional cell–cell adhesion molecule related to LI-cadherin

Experimental cell research, 2004-04, Vol.294 (2), p.345-355

2004

Volltextzugriff (PDF)

Reduction of tumor cell migration and metastasis by adenoviral gene transfer of plasminogen activator inhibitors

Gene therapy, 1999-02, Vol.6 (2), p.227-236

1999

Volltextzugriff (PDF)

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (CIDP), a multicenter randomized double-blind placebo-controlled trial: the Path study

Journal of the neurological sciences, 2017-10, Vol.381, p.59-59

2017

Volltextzugriff (PDF)

Hemostatic activation and inflammatory response during cardiopulmonary bypass: Impact of heparin management

Anesthesiology (Philadelphia), 2002-10, Vol.97 (4), p.837-841

2002

Volltextzugriff (PDF)

Phase I Comparability of Recombinant Human Albumin and Human Serum Albumin

Journal of clinical pharmacology, 2005-01, Vol.45 (1), p.57-67

2005

Volltextzugriff (PDF)

Both u‐PA inhibition and vitronectin binding by plasminogen activator inhibitor 1 regulate HT1080 fibrosarcoma cell metastasis

International journal of cancer, 2002-12, Vol.102 (6), p.584-591

2002

Volltextzugriff (PDF)

A randomized phase II study of a new tick-borne encephalitis vaccine using three different doses and two immunization regimens

Vaccine, 1992, Vol.10 (3), p.145-150

1992

Volltextzugriff (PDF)

The plasma supplemented modified activated clotting time for Monitoring of heparinization during cardiopulmonary bypass: A pilot investigation

Anesthesia and analgesia, 2002-07, Vol.95 (1), p.26-30

2002

Volltextzugriff (PDF)

Prion protein stimulates tissue‐type plasminogen activator‐mediated plasmin generation via a lysine‐binding site on kringle 2

Journal of thrombosis and haemostasis, 2004-06, Vol.2 (6), p.962-968

2004

Volltextzugriff (PDF)

Stimulation of plasminogen activation by recombinant cellular prion protein is conserved in the NH2-terminal fragment PrP23-110

Thrombosis and haemostasis, 2003-05, Vol.89 (5), p.812

2003

Volltextzugriff (PDF)

Both lysine-clusters of the NH2-terminal prion-protein fragment PrP23-110 are essential for t-PA mediated plasminogen activation

Thrombosis and haemostasis, 2004-03, Vol.91 (3), p.465

2004

Volltextzugriff (PDF)

Heparin-level-based anticoagulation management during cardiopulmonary bypass: A pilot investigation on the effects of a half-dose aprotinin protocol on postoperative blood loss and hemostatic activation and inflammatory response

Anesthesia and analgesia, 2004-02, Vol.98 (2), p.285-290

2004

Volltextzugriff (PDF)

Humoral immunity against tick-borne encephalitis virus following manifest disease and active immunization

Vaccine, 1991, Vol.9 (1), p.42-46

1991

Volltextzugriff (PDF)

Update on the toxicology and pharmacology of rDSPA alpha 1 (Bat-PA) in animals and humans

Fibrinolysis & proteolysis, 1997-08, Vol.11, p.55-62

1997

Volltextzugriff (PDF)

The intron 6 G/T polymorphism of c-myb oncogene and the risk for coronary in-stent restenosis

Basic research in cardiology, 2004-07, Vol.99 (4), p.309-314

2004

Volltextzugriff (PDF)

Efficacy and safety of subcutaneous immunologlobulin replacement therapy at Rome in patients with primary immunodeficiency diseases: Combined analysis of two clinical studies, one in North America and one in Europe

CLINICAL IMMUNOLOGY, 2005, Vol.115, p.S251

2005

Volltextzugriff (PDF)

Alert systems for post-marketing surveillance of adverse drug reactions

Statistics in medicine, 1993-12, Vol.12 (24), p.2383-2393

1993

Volltextzugriff (PDF)

DSPA alpha — Properties of the plasminogen activators of the vampire bat Desmodus rotundus

Fibrinolysis, 1995-01, Vol.9, p.91-96

1995

Volltextzugriff (PDF)

Thrombin receptor and urokinase-type plasminogen activator are colocalized in vascular smooth muscle cells derived from human carotid atherosclerotic plaques

Fibrinolysis, 1996-06, Vol.10, p.41-44

1996

Volltextzugriff (PDF)

86 Reduction of tumor cell migration and metastasis by plasminogen activator inhibitor gene transfer

Fibrinolysis & proteolysis, 1997-10, Vol.11, p.25-25

1997

Volltextzugriff (PDF)

Effects of low-molecular weight and high-molecular weight heparin on the intrinsic and extrinsic endogenous fibrinolytic system

Fibrinolysis, 1994, Vol.8, p.71-74

1994

Volltextzugriff (PDF)

Alert systems for post-marketing surveillance of adverse drug events— Methods and problems

Controlled clinical trials, 1991-10, Vol.12 (5), p.659-659

1991

Volltextzugriff (PDF)

La guerre de 1940

Stefan Martens, Steffen Prauser (dir.)

2014

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

The Plasminogen Activator Inhibitor PAI-1 Controls in Vivo Tumor Vascularization by Interaction with Proteases, Not Vitronectin: Implications for Antiangiogenic Strategies

Integrated Database of Eight Prospective IgG Studies in Primary Immunodeficiency: New Tool for Pooled Analysis

Ksp-cadherin is a functional cell–cell adhesion molecule related to LI-cadherin

Reduction of tumor cell migration and metastasis by adenoviral gene transfer of plasminogen activator inhibitors

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (CIDP), a multicenter randomized double-blind placebo-controlled trial: the Path study

Hemostatic activation and inflammatory response during cardiopulmonary bypass: Impact of heparin management

Phase I Comparability of Recombinant Human Albumin and Human Serum Albumin

Both u‐PA inhibition and vitronectin binding by plasminogen activator inhibitor 1 regulate HT1080 fibrosarcoma cell metastasis

A randomized phase II study of a new tick-borne encephalitis vaccine using three different doses and two immunization regimens

The plasma supplemented modified activated clotting time for Monitoring of heparinization during cardiopulmonary bypass: A pilot investigation

Prion protein stimulates tissue‐type plasminogen activator‐mediated plasmin generation via a lysine‐binding site on kringle 2

Stimulation of plasminogen activation by recombinant cellular prion protein is conserved in the NH2-terminal fragment PrP23-110

Both lysine-clusters of the NH2-terminal prion-protein fragment PrP23-110 are essential for t-PA mediated plasminogen activation

Heparin-level-based anticoagulation management during cardiopulmonary bypass: A pilot investigation on the effects of a half-dose aprotinin protocol on postoperative blood loss and hemostatic activation and inflammatory response

Humoral immunity against tick-borne encephalitis virus following manifest disease and active immunization

Update on the toxicology and pharmacology of rDSPA alpha 1 (Bat-PA) in animals and humans

The intron 6 G/T polymorphism of c-myb oncogene and the risk for coronary in-stent restenosis

Efficacy and safety of subcutaneous immunologlobulin replacement therapy at Rome in patients with primary immunodeficiency diseases: Combined analysis of two clinical studies, one in North America and one in Europe

Alert systems for post-marketing surveillance of adverse drug reactions

DSPA alpha — Properties of the plasminogen activators of the vampire bat Desmodus rotundus

Thrombin receptor and urokinase-type plasminogen activator are colocalized in vascular smooth muscle cells derived from human carotid atherosclerotic plaques

86 Reduction of tumor cell migration and metastasis by plasminogen activator inhibitor gene transfer

Effects of low-molecular weight and high-molecular weight heparin on the intrinsic and extrinsic endogenous fibrinolytic system

Alert systems for post-marketing surveillance of adverse drug events— Methods and problems

La guerre de 1940

Suchergebnisse filtern